Intraductal papillary mucinous carcinoma (IPMN) with an associated invasive carcinoma
An invasive malignant epithelial neoplasm arising from the main pancreatic duct or its major branches. Signs and symptoms include epigastric pain, weight loss, jaundice, diabetes, and pancreatitis. It is composed of columnar mucin-containing cells which line dilated ducts and form papillary or pseudopapillary structures. The columnar cells show severe dysplasia and an infiltrating growth pattern.
Intraductal papillary mucinous neoplasms (IPMNs) are intraductal grossly-visible (typically ≥ 1.0 cm) epithelial neoplasms of mucin producing cells, arising in the main pancreatic duct or its branches
Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, Biankin AV, Biankin SA, Compton C, Fukushima N, Furukawa T, Goggins M, Kato Y, Kloppel G, Longnecker DS, Lüttges J, Maitra A, Offerhaus GJ, Shimizu M, Yonezawa S (2004)
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
Am J Surg Pathol 28: 977-87
Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, Yamaguchi K, Yamao K, Matsuno S, (2006)
. Signs and symptoms include epigastric pain, weight loss, jaundice, diabetes, and pancreatitis. The neoplastic epithelium is usually papillary, and the degrees of mucin secretion, duct dilatation (cyst formation), and dysplasia are variable. IPMNs are classified on the basis of the highest degree of cytoarchitectural atypia and invasiveness as:
International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
Pancreatology 6: 17-32
> IPMN with low- to intermediate-grade of dysplasia
, previously called intraductal papillary-mucinous adenoma
> IPMN with high grade of dysplasia
, previously called intraductal papillary-mucinous carcinoma, non-invasive
> IPMN with an associated invasive carcinoma if there is a component of invasive carcinoma.
In case of IPMN with an associated invasive carcinoma , the columnar cells show severe dysplasia and an infiltrating growth pattern. The prognosis is significantly worse than for noninvasive IPMNs; the 5-year survival rates for IPMNs with an associated invasive carcinoma are reported to be between 27% and 60%, depending upon the extent and histological type of the invasive component
Bosman FT, Carneiro F, Hruban RH, Theise ND (Eds.)
WHO Classification of Tumours of the Digestive System.
International Agency for Research on Cancer: Lyon 2010